Azoulay et al. [24] conducted genetic studies on peripheral neuritis in 45 patients with multiple myeloma treated with bortezemib and concluded that SNPs of the BDNF gene are associated with peripheral neuritis caused by chemotherapy. Here, BDNF is linked to plasma cell myeloma.